Home AstraZeneca China Ecosystem Conference 2022 Opens Registration with Theme 'Converge & Strategize for Long-Term Impact'

AstraZeneca China Ecosystem Conference 2022 Opens Registration with Theme 'Converge & Strategize for Long-Term Impact'

Jul 26, 2022 08:00 CST Updated 08:00
AstraZeneca

Cancer Drug Developer

To accelerate the development of China's life and health industry and promote the growth of China's biopharmaceutical industry,Key Side Event of the 2022 Taihu Bay Future Conference on Life and Health – The 5th AstraZeneca China Ecosystem Conference, to be held in Wuxi, on the scenic shores of Lake Taihu.

AstraZeneca remains patient-centric, committed to advancing the development of China’s healthcare industry. It has established a cross-sector collaboration and exchange platform that brings together government, industry, academia, research institutions, healthcare providers, and investors, working with all stakeholders to explore innovative healthcare models and comprehensive disease-management solutions.

After five years of exploration and accumulation, this conference is themed“Convergence · Vision”Centered on this theme, AstraZeneca China will unveil its new innovation development plan and share key achievements from its ecosystem collaborations. The event will bring together industry leaders, high-growth companies, technical experts, and professional investors from both domestic and international life and health sectors to jointly explore medical innovation trends and empower the development of a holistic health ecosystem.


GatherMomentum Empowerment,MeltIntegrated Ecosystem,StrategyPlan the Future, Co-create ExcellenceDistant


987.jpg